Loading…
CIK 0001848809 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("velan-capital-investment-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | $39K | 0.0% | 12,000 SH | |
| ACELYRIN INC | COM | $8.3M | 8.6% | 3,366,945 SH | |
| ACLARIS THERAPEUTICS INC | COM | $54K | 0.1% | 35,000 SH | |
| ALECTOR INC | COM | $68K | 0.1% | 55,000 SH | |
| AVALO THERAPEUTICS INC | COM NEW | $897K | 0.9% | 111,972 SH | |
| CONTEXT THERAPEUTICS INC | COM | $55K | 0.1% | 90,000 SH | |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $313K | 0.3% | 59,000 SH | |
| CYTOMX THERAPEUTICS INC | COM | $48K | 0.0% | 75,000 SH | |
| DESIGN THERAPEUTICS INC | COM | $54K | 0.1% | 14,000 SH | |
| EDESA BIOTECH INC | COM NEW | $1.7M | 1.7% | 687,500 SH | |
| ELEDON PHARMACEUTICALS INC | COM | $1.1M | 1.1% | 323,973 SH | |
| ELEVATION ONCOLOGY INC | COM | $12K | 0.0% | 45,000 SH | |
| ERASCA INC | COM | $69K | 0.1% | 50,000 SH | |
| GERON CORP | COM | $1.0M | 1.1% | 655,000 SH | |
| GOSSAMER BIO INC | COM | $83K | 0.1% | 75,000 SH | |
| HERON THERAPEUTICS INC | COM | $15.4M | 15.8% | 6,986,744 SH | |
| IMMUNOME INC | COM | $1.0M | 1.1% | 153,500 SH | |
| INSPIREMD INC | COM | $2.4M | 2.5% | 904,029 SH | |
| INSTIL BIO INC | COM NEW | $1.2M | 1.2% | 69,000 SH | |
| JASPER THERAPEUTICS INC | COM NEW | $6.2M | 6.3% | 1,433,828 SH | |
| KIORA PHARMACEUTICALS INC | COM | $368K | 0.4% | 122,223 SH | |
| KRONOS BIO INC | COM | $29K | 0.0% | 35,000 SH | |
| LARIMAR THERAPEUTICS INC | COM | $60K | 0.1% | 28,000 SH | |
| LIQUIDIA CORPORATION | COM NEW | $4.4M | 4.6% | 300,000 SH | |
| MINERALYS THERAPEUTICS INC | COM | $2.4M | 2.5% | 150,600 SH | |
| NEXTCURE INC | COM | $12K | 0.0% | 25,000 SH | |
| OVID THERAPEUTICS INC | COM | $30K | 0.0% | 97,000 SH | |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | $1.1M | 1.1% | 500,000 SH | |
| PMV PHARMACEUTICALS INC | COM | $38K | 0.0% | 35,000 SH | |
| PRAXIS PRECISION MEDICINES I | COM NEW | $7.0M | 7.2% | 185,000 SH | |
| PROQR THRAPEUTICS N V | SHS EURO | $60K | 0.1% | 45,000 SH | |
| PROTARA THERAPEUTICS INC | COM STK | $7.1M | 7.3% | 1,667,800 SH | |
| REGULUS THERAPEUTICS INC | COM | $140K | 0.1% | 80,000 SH | |
| REPLIMUNE GROUP INC | COM | $1.8M | 1.8% | 182,083 SH | |
| REZOLUTE INC | COM NEW | $1.2M | 1.2% | 400,000 SH | |
| SCPHARMACEUTICALS INC | COM | $2.4M | 2.5% | 917,668 SH | |
| SPRINGWORKS THERAPEUTICS INC | COM | $8.2M | 8.4% | 185,520 SH | |
| SUTRO BIOPHARMA INC | COM | $670K | 0.7% | 1,030,000 SH | |
| TELA BIO INC | COM | $912K | 0.9% | 747,410 SH | |
| TENAX THERAPEUTICS INC | COM NEW | $546K | 0.6% | 83,333 SH | |
| TERNS PHARMACEUTICALS INC | COM | $47K | 0.0% | 17,000 SH | |
| TOURMALINE BIO INC | COM | $6.9M | 7.1% | 455,412 SH | |
| UPSTREAM BIO INC | COM | $655K | 0.7% | 107,000 SH | |
| VENTYX BIOSCIENCES INC | COM | $46K | 0.0% | 40,000 SH | |
| VERONA PHARMA PLC | SPONSORED ADS | $6.0M | 6.2% | 95,000 SH | |
| WAVE LIFE SCIENCES LTD | SHS | $105K | 0.1% | 13,000 SH | |
| ZEVRA THERAPEUTICS INC | COM NEW | $5.0M | 5.1% | 665,000 SH |
| 13F-HR |
| 0001848809-26-000003 |
| $164.2M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001848809-25-000005 | $101.2M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001848809-26-000002 | $159.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000938552-25-000003 | $97.2M | View |